U.S. market Closed. Opens in 1 hour 21 minutes

CNCR | Loncar Cancer Immunotherapy ETF Holdings

(Stock Exchange: NASDAQ)
Symbol Name Market Cap Weight Valuation Profitability Growth Health 200SMA Price Change IV IV Rank
TIL Instil Bio, Inc. 127.97M 3.59%
19.61 -6.49% 576.12% 75.97%
REPL Replimune Group, Inc. 892.78M 3.54%
11.85 16.86% 100.82% 7.48%
IOVA Iovance Biotherapeutics, Inc. 1.79B 3.47%
5.88 -0.51% 36.66% 17.90%
ZYME Zymeworks Inc. 984.26M 3.45%
14.29 2.95% 87.55% 25.80%
ARGX argenx SE 39.08B 3.42%
647.39 1.07% 34.52% 12.76%
GMAB Genmab A/S 13.85B 3.42%
21.80 4.81% 45.54% 65.90%
AZN AstraZeneca PLC 210.75B 3.39%
67.96 2.04% 29.19% 69.45%
BMY Bristol-Myers Squibb Company 115.69B 3.39%
57.04 1.33% 26.07% 39.82%
CRSP CRISPR Therapeutics AG 3.54B 3.39%
41.51 2.42% 58.04% 23.81%
MRK Merck & Co., Inc. 243.45B 3.37%
96.24 -1.72% 29.23% 82.06%
NKTR Nektar Therapeutics 166.75M 3.37%
0.9040 1.35% 283.34% 65.14%
XNCR Xencor, Inc. 1.43B 3.37%
20.45 6.29% 128.99% 67.83%
REGN Regeneron Pharmaceuticals, Inc. 74.33B 3.36%
687.80 0.91% 35.86% 61.72%
FATE Fate Therapeutics, Inc. 150.34M 3.33%
1.3200 3.94% 316.25% 37.38%
GILD Gilead Sciences, Inc. 115.85B 3.33%
92.96 1.22% 24.35% 38.35%
RCUS Arcus Biosciences, Inc. 1.29B 3.32%
14.14 0.78% 284.48% 31.92%
ATRA Atara Biotherapeutics, Inc. 34.85M 3.30%
6.05 -7.91% 769.79% 94.72%
ALLO Allogene Therapeutics, Inc. 385.80M 3.29%
1.8400 1.10% 408.42% 43.75%
RUBY Rubius Therapeutics, Inc. 3.29%
TRIL Trillium Therapeutics Inc. 3.29%
BLUE bluebird bio, Inc. 79.14M 3.28%
8.14 -2.52% 126.16% 25.42%
IBRX ImmunityBio, Inc. 2.35B 3.28%
3.22 9.52% 193.35% 35.33%
IMAB I-Mab 88.16M 3.25%
1.0900 1.87% 546.25% N/A
IGMS IGM Biosciences, Inc. 101.68M 3.23%
1.7100 -3.39% 187.84% 100.00%
STTK Shattuck Labs, Inc. 54.90M 3.23%
1.1500 3.60% 586.39% 69.78%
ALXO ALX Oncology Holdings Inc. 87.03M 3.21%
1.6500 -5.17% 253.46% 31.49%
LEGN Legend Biotech Corporation 6.36B 3.20%
34.67 6.15% 67.19% 31.66%
BGNE BeiGene, Ltd. 20.21B 3.19%
184.71 0.49% 39.65% 32.18%
MGNX MacroGenics, Inc. 188.29M 3.17%
3.00 0.00% 210.63% 12.85%
YMAB Y-mAbs Therapeutics, Inc. 277.24M 3.12%
6.19 0.49% 312.11% 50.19%
Cash&Other 0.13%
Total holdings: 31 Recognized Stocks: 28 Others: 3
An error has occurred. This application may no longer respond until reloaded. Reload 🗙